Press Releases
-
Upgrading to FFP3 face masks in hospitals could save the NHS £360m a year and help slash patient waiting lists
The NHS could save up to £360M per year by using FFP3 face masks and the NHS already has a large stockpile of these masks so there is no current need to purchase more. Independent studies commissioned by PPE manufacturer Globus Group and carried out by York Economic Health Consortium and Vital Economics confirm that these masks may be better at preventing respiratory infection and resulting staff days off.
Nov 30, 2022
-
Scipio bioscience Announces a Single-Cell Grant Program for Four Researchers to Receive a Complete 3′ scRNA-seq Solution Valued up to US$30,000
Scipio bioscience has announced a grant program for researchers to receive a complete 3′ scRNA-seq solution valued at up to US$30,000.
Nov 30, 2022
-
CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis
Nov 30, 2022
-
Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process
Nov 13, 2022
-
Creative Proteomics Lipidomics Launches Ceramides Analysis Service
Nov 12, 2022
-
Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service
Nov 21, 2022
-
Dolomite Bio launches RNAdia 2.0 Reagent Kit – Fast, Easy, Robust
Dolomite Bio has announced the launch of the RNAdia 2.0 reagent kit for single cell research. At a significantly lower cost compared to competitor reagents the new and improved RNAdia 2.0 kit alleviates that stress, allowing researchers to focus on what is important, doing more and discovering more.
Nov 29, 2022
-
UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Solutions for the Cell and Gene Therapy Industry
BioPharma Dynamics has announced the expansion of its extensive portfolio to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors, for the Cell & Gene Therapy market.
Nov 29, 2022
-
Biopharma PEG Develops PEG Products For Click Chemistry
Nov 29, 2022
-
Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes
Nov 28, 2022
-
Genezen appoints Chief Commercial Officer to Executive Leadership Team
Genezen appoints Jeff Whitmore as CCO
Nov 28, 2022
-
Andelyn Biosciences to Manufacture First Gene Therapy for Infantile Neuroaxonal Dystrophy in the US
Nov 28, 2022
-
Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends
Nov 28, 2022
-
Creative Enzymes Provides DNA Molecular Weight Markers and Ladders
Nov 14, 2022
-
CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing
Nov 18, 2022
-
MicrobioSeq Boosts Scientific Research with Gene Expression Analysis
Nov 14, 2022
-
Micro-Sphere Launches New Research & Development Services at Swiss Site
Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.
Nov 27, 2022
-
Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas
Nov 27, 2022
-
IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications
Nov 27, 2022
-
Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics
Nov 27, 2022






